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Conclusions	
Sleep disturbance is prevalent among patients who 
have suffered from stroke, and poor sleep may 
have an impact on stroke recovery. Suboptimal 
sleep has been linked to poor cognition and 
memory in those with neurodegenerative disease, 
and even normal adults. This relationship may 
carry clinical implications about the sleep needs of 
stroke patients who are receiving speech and 
language therapy during their rehabilitation. 
 
Studies that explicitly address the effects of sleep 
on speech and language outcomes post-stroke are 
scarce, though we came across a variety of studies 
which measured multiple outcome domains that 
are closely linked to speech and language 
processes. These included measures of overall 
cognition, memory, attention, executive function, 
reaction time, vigilance, and motor learning. 
Introduc@on	
Results	
•  There is mixed evidence for a positive effect of 
sleep on stroke outcomes related to speech and 
language. 
•  CPAP non-compliance is a major barrier to  
evaluating its effect on stroke outcomes.  
•  Most studies were limited by small sample size.  
•  Only two studies directly investigated language 
outcomes, and these authors excluded patients 
with severe aphasia. Therefore, we need studies 
that specifically address this population. 
•  A few studies looked for differences in MMSE 
among high-functioning patients, and ceiling 
effects likely came into play.  
•  Animal studies were consistent but the results 
need to be replicated in humans. 
•  7 out of 12 human studies showed significant 
effects on motor outcomes, while less than half of 
those showed significant differences in cognitive 
measures. 
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•  All three reviewers independently decided to 
include or exclude at the title/abstract and full 
text level. 
•  Evidence levels were established by 
independent double appraisal and reviewer 
discussion of discrepancies in order to reach 
consensus. 
Domain	 Article	 Measures	 Results	
Overall 
Cognition	
Aaronson 2015	 Canadian Neurological Scale (CNS)	 Significant difference in CNS total score between SA+ and SA- groups (p = 0.01, d = 0.47)	
Ryan 2011	 Canadian Neurological Scale (CNS) –  total score and cognitive subscale	
Significant differences between control and CPAP groups in change in CNS total score (p = 0.001) and CNS cognitive 
subscale score (p = 0.01) over 1-month period.	
Sandberg 2001 Mini-Mental State Examination (MMSE) No significant difference between SA+ and SA- groups (p = 0.206).	
Siccoli 2008 Mini-Mental State Examination (MMSE) 
MMSE scores correlated with WASO scores (r = -0.855; p = 0.003), sleep efficiency measures (r = 0.818; p = 0.007), and 
amount of REM sleep (r = 0.708; p = 0.033).	
Siengsukon 2009 “Sleep enhances…” Mini-Mental State Examination (MMSE) SA+ group scored 15.9±8.5 while SA- group scored 17.8±8.3. No significant difference (p = .209).	
Language	 Aaronson 2015	 Category Fluency Test for verbal fluency 
No significant difference was found between OSA and non-OSA stroke patients (p = 0.41).	
Aaronson 2016	 Category Fluency Test for verbal fluency No significant difference was found between stroke patients in CPAP treatment and control groups (p = 0.11).	
Attention	
Aaronson 2015 D2 Test of Attention 	 OSA patients had significantly lower attention scores than non-OSA controls (p < 0.01).	
Aaronson 2016 D2 Test of Attention OSA patients with CPAP performed significantly better than controls (p = 0.05, partial eta squared = 0.09).	
Ryan 2011 Sustained attention response time No significant difference found between CPAP treated patients and controls (p=0.32).	
Siccoli 2008 D2 Test of Attention 
Attention positively correlated with sleep efficiency (r = 0.850, p = 0.004) and negatively correlated with wake after sleep 
onset (r = -0.864, p = 0.003).	
Memory	
Aaronson 2015 	 Rey Auditory Verbal Learning Test OSA patients did not perform significantly better than controls (p=0.39).	
Aaronson 2016 Rey Auditory Verbal Learning Test CPAP patients did not perform significantly better than controls (p=0.32).	
Gomez 2008 Rey Auditory Verbal Learning Test, Rey-Osterreith Complex Figure Test 
No significant improvement after a night of sleep.	
Siccoli 2008 CVLT and Rey Visual Design Learning Test	
Wake after sleep onset correlated significantly with poor performance on tests of verbal memory (p<0.05) and figural 
memory (p<0.01) while sleep efficiency improved performance significantly (p<0.05). REM sleep correlated significantly with 
more memory measures than slow-wave sleep. 
Working 
Memory	
Aaronson 2015 WAIS-III Letter-Number Sequencing OSA patients did not perform significantly better than controls (p=0.10).	
Aaronson 2016 WAIS-III Letter-Number Sequencing 
CPAP patients did not perform significantly better than controls (p=0.16).	
Gomez 2008 “2-back” (Modified N-back) No significant  improvement after a night of sleep.	
Ryan 2011 Digit span backwards (visuo-spatial span for aphasic patients) 
CPAP patients showed significant improvement on digit (or V.S.) span backward, while those without CPAP did not. 
However, the between-group difference was not significant.	
Motor	
Aaronson 2015 Finger Tapping Test OSA patients had significantly lower psychomotor ability than non-OSA patients (p < 0.01).	
Aaronson 2016 Finger Tapping Test CPAP patients did not perform significantly better than controls (p = 0.45).	
Gomez 2008 Serial Reaction Time Task (SRTT) 
Patients with prefrontal lesions improved overnight on a motor learning test (p<0.001) while parietals did not show significant 
learning.	
Kim 2015 
Hand strength test, 
Purdue Pegboard, 
9-hole peg test 
Good sleepers did not show significantly different performance on any of the motor outcomes compared to poor sleepers.	
Lefevre-Dognin 2014 Fugl Meyer score 
SAS patients were not significantly different from non-SAS patients, neither at baseline (p = 0.76) nor after 2 months (p = 
0.20).	
Ryan 2011 6-minute walk distance, Berg Balance Scale, CNS motor subscale 
CPAP patients showed a significant increase in 6-minute walk distance after 1 month (p = 0.02) and CNS motor subscale (p 
= 0.001), whereas control patients did not improve. Both groups showed significant improvement in Berg Balance Scale 
score over baseline (p = 0.001 for controls, p = 0.01 for CPAP group).	
Sandberg 2001	 Organic Brain Syndrome Scale (OBS) –  confusion subscale 	
Psychomotor slowing was not significantly different between post-stroke patients with AHI ≥10 and those with AHI < 10 (p = 
0.225).	
Siengsukon 2015 Motor learning – continuous tracking task 
After 3 consecutive days of sleep after baseline, post-stroke individuals demonstrated a significant improvement in tracking 
(p = 0.006) while the neurologically intact controls did not (p = 0.816).	
Siengsukon 2008 Motor learning – continuous tracking task 
Post-stroke individuals who slept exhibited a significant improvement in tracking (p = 0.018, effect size = 0.764). Post-stroke 
individuals who did not sleep did not (p = 0.467). Neither control group showed improvement (p = 0.702 for sleep group, p = 
0.458 for no-sleep group).	
Siengsukon 2009 
“Sleep to learn after stroke…” Motor learning – continuous tracking task 
Post-stroke individuals who slept exhibited a significant improvement in tracking over stroke patients who did not sleep (p = 
0.006). Controls who slept did not show a significant improvement over controls who did not (p = 0.816).	
Siengsukon 2009 
“Sleep enhances…” Motor learning – continuous tracking task 
Post-stroke individuals who slept exhibited significant temporal motor learning (p = 0.036) and spatial learning (p = 0.014) 
while post-stroke individuals who did not sleep did not exhibit either (p = 0.962 for temporal, p = 0.556 for spatial). Spatial 
tracking did not improve in either of the control groups (p = 0.578 for sleep, p = 0.776 for no-sleep).	
Motor-  
Animal Studies	
Gao 2008 Grip strength 
Post-stroke mice given GHB (a slow-wave sleep promoting drug), showed significant grip-strength restoration compared to 
controls at 3 weeks, but the effect was no longer significant at 5 weeks.	
Hodor 2014 SPR (single-pellet reaching task) 
Post-stroke rats given baclofen, a non-REM sleep promoting drug, performed significantly better on SPR task than controls. 
(only significant in rats with right-hemisphere lesions).	
Zunzunegui 2011 SPR 	
Post-stroke rats were sleep-deprived and performance on SPR was significantly worse than sleeping counterparts starting at 
2 weeks.	
Vigilance	
Aaronson 2015 Psychomotor Vigilance Task (PVT) No significant difference was found between OSA and non-OSA stroke patients in PVT score (p = 0.08).	
Aaronson 2016 Psychomotor Vigilance Task (PVT) No significant differences were found between stroke patients in CPAP treatment and control groups in PVT score (p = 0.34).	
Executive 
Function	
Aaronson 2015	 Tower of London	 A significant difference was found between OSA and non-OSA stroke patients on Tower of London test (p = 0.02, d = 0.42).	
Aaronson 2016 Tower of London	
A significant difference was found between stroke patients in CPAP treatment and control groups in Tower of London test (p < 
0.01, partial eta-squared = 0.26).	
Intelligence	
Aaronson 2015	 WAIS-III Matrix Reasoning 
A significant difference was found between OSA and non-OSA stroke patients in WAIS-III Matrix Reasoning score (p = 0.01, 
d = 0.44).	
Aaronson 2016 WAIS-III Matrix Reasoning 
No significant difference in WAIS-III Matrix Reasoning Score was found between stroke patients in CPAP treatment and 
control groups (p = 0.33).	
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 First Author & Year  Group(s) Limitations 
 Aaronson 2015 OSA (n = 80) and non-OSA (n = 67). Study evaluated language but omitted subjects with severe aphasia 
 Aaronson 2016 4 weeks of CPAP treatment (n = 20) or treatment as usual (n = 16). CPAP compliance low (11/20 subjects, note that ITT was used in their analysis) 
 Gao 2008 Mice with ischemic surgery/GHB (n = 7), ischemic surgery/saline (n = 6), sham surgery/saline (n = 6), and sham surgery/GHB treatment (n = 6). Might not translate to humans 
 Gomez 2008 Patients with prefrontal lesions (n=14), parietal lesions (n=5), healthy controls (n=15) Duration of study, sleep deprived control would perhaps have been preferable 
 Hodor 2014 Ischemic rats (Bac treatment vs. control) Might not translate to humans 
 Kim 2015 Patients post-stroke (n = 80) Nature of study allows for numerous confounders 
 Lefevre-Dognin 2014 SAS+ (n = 28) and SAS- (n = 15) as defined by AHI ≥ 10 respectively. Significant age differences between SAS+ and SAS- groups (p = 0.004); irregular administration time of BAWL 
 Ryan 2011 CPAP vs. no CPAP treatment (n=22,22) 12% CPAP noncompliance 
 Sandberg 2001 Patients post-stroke (n = 133) who fulfilled criteria for sleep apnea (n = 78), defined by AHI ≥ 10. Sleep apnea group had significantly higher rates of previous cerebral infarction and ischemic heart disease 
 Siccoli 2008 Patients with first ever acute stroke (n=11). Compared to 5 age-matched controls Small sample size and variation in time of follow-up examinations performed during recovery phase (ranged from 3 to 12 months) 
 Siengsukon 2008 Post-stroke individuals (n = 18) vs. age-matched neurologically intact controls (n = 18), divided into sleep (n = 9) and no-sleep (n = 9) subgroups Pseudo-randomized, time-of-day effect confounder, sleep quality not assessed 
 Siengsukon 2009 Stroke pts assigned to test in the evening and retest in the morning (after sleep) vs. test in the morning and retest in the evening (no sleep)  Pseudo-randomized, time-of-day effect confounder, sleep quality not assessed 
 Siengsukon 2009 Post MCA stroke individuals (n = 15) vs. age and sex matched controls (n = 15), divided into sleep (n = 8) and no-sleep (n = 7) subgroups No effect size given; SEM error bars overlapped between stroke-sleep and stroke-nosleep groups: not likely to be clinically significant 
 Siengsukon 2015 Post-stroke individuals >6 months following stroke (n = 20) vs. neurologically intact controls (n = 10) Small sample size 
 Zunzunegui 2011 Ischemic rats with sleep vs. sleep deprivation Might not translate to humans 
 Baumann 2014 Post-stroke patients Data is not presented in a way that shows the relationship between sleep and outcomes (confounders not accounted for) 
 Hsu 2006 Post-stroke patients with AHI ≥ 30 receiving CPAP (n = 15) vs. those not receiving CPAP (n = 15) Low CPAP treatment compliance: mean of 1.4 h/night, median of 0.16 h/night; mean exceeded 6h in only two patients 
 Kim 2010 Post-stroke patients with insomnia treated with hypnotics (n = 15) vs. post stroke patients w/o insomnia (no treatment, n = 15) No appropriate control 
 Sandberg 2001 Post-stroke patients with AHI >= 10 (n = 78) and post-stroke patients with AHI < 10 (n = 55) Low CPAP treatment compliance: mean of 4.1 +/- 3.6 h/night (range 0-10.9h), 15/31 patients used for <4 h/night 
Figure	1:	Summary	of	quality	appraisal	ﬁndings	by	author.	Key:	Good	quality:	Green,	Adequate:	Yellow,	Poor:	Red	
Figure	2:	Summary	of	study	ﬁndings	by	domain.	Key:	Signiﬁcant:	Green,	Non-signiﬁcant:	Yellow	
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